Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pelagia Katsimbri

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Mediterranean Journal of Rheumatology|January 29, 2026
Psoriatic Arthritis: Developments in 2025Christina Spanopoulou, Pelagia Katsimbri
Immunotherapy|June 18, 2024
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapyKaterina Kampoli, Ioannis Tsamis, Dimitrios Sgouros, et al.
Dermatologic Therapy|February 25, 2020
How does the joint dermatology-rheumatology clinic benefit both patients and dermatologists?Elina Theodorakopoulou, Maria Dalamaga, Pelagia Katsimbri, et al.
Rheumatology (Oxford, England)|June 26, 2016
Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosusTheofanis Karageorgas, Athanasios Zomas, Pinelopi Kazakou, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Imaging Risk in Multisystem Inflammatory DiseasesIgnatios Ikonomidis, George Makavos, Pelagia Katsimbri, et al.
Rheumatology International|March 14, 2003
Early rheumatoid arthritis patients: relationship of ageIoannis A Papadopoulos, Pelagia Katsimbri, Yannis Alamanos, et al.
The American Journal of the Medical Sciences|August 15, 2022
Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumabGeorgios Tsioulos, Dimitris Kounatidis, Natalia G Vallianou, et al.
Lupus|December 9, 2022
Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center studyGeorgia-Savina Moysidou, Panagiotis Garantziotis, Dionysis Nikolopoulos, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 8, 2011
Age-related differences of bone mass, geometry, and strength in treatment-naïve postmenopausal women. A tibia pQCT studyKonstantinos D Stathopoulos, Pelagia Katsimbri, Erato Atsali, et al.
Clinical Rheumatology|March 13, 2024
Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trialPanagiotis Athanassiou, Pelagia Katsimbri, Andreas Bounas, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Mediterranean Journal of Rheumatology|January 29, 2026
Psoriatic Arthritis: Developments in 2025Christina Spanopoulou, Pelagia Katsimbri
Immunotherapy|June 18, 2024
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapyKaterina Kampoli, Ioannis Tsamis, Dimitrios Sgouros, et al.
Dermatologic Therapy|February 25, 2020
How does the joint dermatology-rheumatology clinic benefit both patients and dermatologists?Elina Theodorakopoulou, Maria Dalamaga, Pelagia Katsimbri, et al.
Rheumatology (Oxford, England)|June 26, 2016
Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosusTheofanis Karageorgas, Athanasios Zomas, Pinelopi Kazakou, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Imaging Risk in Multisystem Inflammatory DiseasesIgnatios Ikonomidis, George Makavos, Pelagia Katsimbri, et al.
Rheumatology International|March 14, 2003
Early rheumatoid arthritis patients: relationship of ageIoannis A Papadopoulos, Pelagia Katsimbri, Yannis Alamanos, et al.
The American Journal of the Medical Sciences|August 15, 2022
Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumabGeorgios Tsioulos, Dimitris Kounatidis, Natalia G Vallianou, et al.
Lupus|December 9, 2022
Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center studyGeorgia-Savina Moysidou, Panagiotis Garantziotis, Dionysis Nikolopoulos, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 8, 2011
Age-related differences of bone mass, geometry, and strength in treatment-naïve postmenopausal women. A tibia pQCT studyKonstantinos D Stathopoulos, Pelagia Katsimbri, Erato Atsali, et al.
Clinical Rheumatology|March 13, 2024
Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trialPanagiotis Athanassiou, Pelagia Katsimbri, Andreas Bounas, et al.
Pageof 5